Figure 1.
Clinical Data
(A) Wearable heart rate monitor trend. (B) Twelve-lead electrocardiogram showing 2:1 atrioventricular block. (C) Chest radiography showing prominent hila. (D) Computed tomography showing mediastinal, bilateral hilar and bilateral intrapulmonary adenopathy. (E) Positron emission tomography showing increased 18F-fluorodeoxyglucose uptake at the inferolateral base, midportion of the inferolateral wall, and lateral wall of the right ventricle, consistent with an active inflammatory process. (F) Cardiac magnetic resonance imaging showing multiple foci of midmyocardial to subepicardial delayed enhancement.